Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-060256·Larimar Therapeutics, Inc.
Schedule 13G ownership disclosure
LARIMAR THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 517125100
Event date: 2025-06-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Millennium Management LLC
Shares: 3,563,602.00 · Class: 5.6%
- Millennium Group Management LLC
Shares: 3,563,602.00 · Class: 5.6%
- Israel A. Englander
Shares: 3,563,602.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-060256
- Form type
- SCHEDULE 13G
- Filer
- Larimar Therapeutics, Inc.
- CIK
- CIK 1374690
- Filed
- Jun 17, 2025
- Reporting period
- Jun 12, 2025
- Description
- Schedule 13G beneficial ownership